Zevra Therapeutics, Inc. (ZVRA)
8.58
-0.02
(-0.23%)
USD |
NASDAQ |
Feb 09, 16:00
8.58
0.00 (0.00%)
After-Hours: 16:58
Zevra Therapeutics Market Cap : 483.03M for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| XOMA Royalty Corp. | 294.22M |
| Verastem, Inc. | 500.88M |
| ADMA Biologics, Inc. | 3.898B |
| ACADIA Pharmaceuticals, Inc. | 3.927B |
| Alnylam Pharmaceuticals, Inc. | 42.27B |
Market Cap Related Metrics
| PE Ratio | 13.60 |
| PS Ratio | 5.554 |
| Price to Book Value | 3.627 |
| Price | 8.58 |
| Earnings Yield | 7.35% |
| Normalized PE Ratio | 6.000 |